Zdrowie i gospodarka · 03/07/2002

FDA Clears the Way for Approval of Piperacillan for Injection USP, 40-G Pharmacy Bulk Package

The Food and Drug Administration (FDA) has determined that piperacillan for injection USP, a 40-gram pharmacy bulk package, was not withdrawn from sale due to safety or effectiveness concerns. This decision enables the FDA to approve abbreviated new drug applications (ANDAs) for piperacillan for injection USP, 40-g pharmacy bulk package.